Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.
The week at Retraction Watch featured:
- Drug company withdraws court motion requesting retraction of papers critical of its painkiller
- “Yep, pretty slow”: Nutrition researchers lose six papers
- “We didn’t want to hurt them. We are polite”: When a retraction notice pulls punches
- Who owns your thesis data? We do, says one university, prompting retraction
- Clinical trial paper that made anemia drug look safer than it is will be retracted
- Authors yank ketamine study, hoping it will go away without attention, and journal obliges
Our list of retracted or withdrawn COVID-19 papers is up to 125.
Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):
Continue reading Weekend reads: Government interference in research; ‘mega’ reviewers; tobacco funding draws scrutiny